BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Neonatal Abstinence Syndrome

Below is an extended Neonatal Abstinence Syndrome research listing. Click here to return to the Neonatal Abstinence Syndrome main in depth entry.

Recent Publications on Neonatal Abstinence Syndrome:

Benign neonatal sleep myoclonus in newborn infants of opioid dependent mothers.
Objective: The aim of our study was to evaluate the incidence, duration...
Direct Link
23rd September, 2008
Clinic for Neonatology, University Hospital Zurich, Zurich, Switzerland.
Sublingual buprenorphine for treatment of neonatal abstinence syndrome: a randomized trial.
OBJECTIVE: In utero exposure to drugs of abuse can lead to neonatal...
Direct Link
17th September, 2008
Department of Pharmacology and Experimental Therapeutics, Jefferson
Chronic hepatitis C in pregnancy.
OBJECTIVE: To estimate outcomes, to determine whether appropriate...
Direct Link
17th September, 2008
Division of Maternal-Fetal Medicine, Department of Obstetrics and
A new look at the neonate's clinical presentation after in utero exposure to antidepressants in late pregnancy.
OBJECTIVES: To identify symptoms in neonates exposed to antidepressants in...
Direct Link
13th September, 2008
Perinatalogy Unit, Saint-Francois d'Assise Hospital, CHUQ Research Center,
Treating pregnant women dependent on opioids is not the same as treating pregnancy and opioid dependence: a knowledge synthesis for better treatment for women and neonates.
AIMS: Through a novel synthesis of the literature and our own clinical...
Direct Link
12th September, 2008
Department of Psychiatry and Psychotherapy, Medical University Vienna,
Slow-release morphine was not more effective than methadone in reducing neonatal abstinence syndrome. 30th August, 2008
A model program: neonatal nurse practitioners providing community health care for high-risk infants. 16th August, 2008
University of Miami School of Nursing and Health Studies, USA.
Correlations of Maternal Buprenorphine Dose, Buprenorphine, and Metabolite Concentrations in Meconium with Neonatal Outcomes.
For the first time, relationships among maternal buprenorphine dose,...
Direct Link
15th August, 2008
1Chemistry and Drug Metabolism, Intramural Research Program, National
Drugs and pregnancy--outcomes of women engaged with a specialist perinatal outreach addictions service.
Substance misuse during pregnancy may result in harm to both mother and...
Direct Link
13th August, 2008
National Addiction Centre, Institute of Psychiatry, King's College London,
Neonatal abstinence syndrome.
OBJECTIVE: In utero exposure to drugs of abuse can lead to neonatal...
Direct Link
7th August, 2008
The Center for Addiction and Pregnancy, Johns Hopkins Bayview Medical
[Long live rooming-in] 1st August, 2008
CHUM.
Comparison of chlorpromazine versus morphine hydrochloride for treatment of neonatal abstinence syndrome.
AIM: To compare the duration of treatment for neonatal abstinence syndrome...
Direct Link
23rd July, 2008
CHU de Montpellier, Service neonatologie, Hopital Arnaud De Villeneuve,
Neonatal Abstinence Syndrome.
OBJECTIVE. TO STUDY THE SUBSTANCE MISUSE IN PREGNANT MOTHERS AND ITS...
Direct Link
28th June, 2008
The Great Western Hospital, 21 Tansley Moor, Swindon, SN3 6NA, Wiltshire,
Management of chemical dependence in pregnancy.
Although the percentage of pregnant patients who use illicit drugs is...
Direct Link
28th June, 2008
Addiction Medicine Services, Detroit Medical Center, Wayne State
Neonatal outcome of 58 infants exposed to maternal buprenorphine in utero.
AIM: To study the neonatal outcome of infants exposed to buprenorphine in...
Direct Link
14th May, 2008
Hospital for Children and Adolescents, Helsinki University Central
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional